Autologous Mesenchymal Stem Cells (intrathecal)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous Mesenchymal Stem Cells (intrathecal), covering 2025-12-18 to 2025-12-18. Get the full timeline:
Most recent: Clinical Trial Update: Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy [Phase 2]